OpenVSafe by OpenVAERS
Search V-safe

UVS-25126-06327

3 vaccinations 4 coded responses 12 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
480 / MI
Registered
2021-10-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-13
    Dose 2 — Pfizer-BioNTech
  3. 2021-10-15
    Dose 3 — Pfizer-BioNTech
  4. 2021-10-16
    Registered in v-safe
  5. 2021-10-16
    Survey response — days 1–6 daily, dose 3
    MedDRA: Pregnancy — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Pregnancy
    MedDRA releases: 2024-11 · check-in free text available
  6. 2021-10-17
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Enlarged axillary lymph node with pain
    MedDRA releases: 2024-11 · check-in free text available
  7. 2021-10-18
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  8. 2021-10-20
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2021-10-21
    Survey response — days 1–6 daily, dose 3
    MedDRA: Abortion spontaneous — Feeling: Good
    Free text: Miscarriage
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-10-22
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  11. 2021-11-05
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  12. 2021-11-12
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  13. 2021-11-21
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  14. 2021-11-26
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-01-14
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-04-15
    Survey response — 6 months, dose 3
    MedDRA: COVID-19, Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: COVID -19 diagnosed 4/7/22 Pregnancy EDD 9/28/22
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech No
22021-01-13Pfizer-BioNTech No
32021-10-15Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 3

2021-10-16

Systemic reaction (other): Pregnancy

2021-10-17

Systemic reaction (other): Enlarged axillary lymph node with pain

2021-10-21

Systemic reaction (other): Miscarriage

Release 11 — 6 months, dose 3

2022-04-15

Symptoms: COVID -19 diagnosed 4/7/22 Pregnancy EDD 9/28/22

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDPregnancy · · ✓
SROAbortion spontaneous · · ✓
SROLymph node pain · · ✓
SROLymphadenopathy · · ✓
SROPregnancy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…